PUS7 and cancer: Dysregulation of PUS7 has been implicated in various pathological contexts, including various types of cancer, where it contributes to oncogenic processes such as cell proliferation, metastasis, metabolic reprogramming, and evasion of apoptosis (Table 2 and Table 3).